Raised $1.7B across disclosed rounds.[5]

Post-IPO Equity closed December 2022, led by Foris Ventures, LLC.[7]

post-money valuation is not publicly disclosed.

Named investors include Foris Ventures, LLC, Vivo Capital LLC, Jefferies LLC, Cowen and Company LLC, Oppenheimer & Co. Inc., H.C. Wainwright & Co..[1][2][7][8][9]

Kathy Fortmann, Chief Executive Officer[4][10][11][12][13][14][16]

Sunil Chandran, Chief Technology Officer[4][10][11][12][13][14][16]

Lisa Roessler, Chief Commercial Officer[4][10][11][12][13][14][16]

Adam Blaziak, Chief Operations Officer[4][10][11][12][13][14][16]

Han Kieftenbeld, Chief Financial Officer (as of 2020)[4][10][11][12][13][14][16]

Annie Tsong, SVP, Corporate & Scientific Affairs[4][10][11][12][13][14][16]

Brian Edquist, SVP, Portfolio Management & Computing[4][10][11][12][13][14][16]

John Hung, Director of Technology Partnerships[4][10][11][12][13][14][16]

Adam Meadows, Director of Data Science[4][10][11][12][13][14][16]

Kevin George, Director of Automated Strain Engineering[4][10][11][12][13][14][16]

Ginkgo Bioworks · ginkgobioworks.com · Same buyer (CPG and industrial partners seeking bio-manufactured ingredients), same job to be done (strain engineering and fermentation scale-up), and named together in market maps as competing synthetic biology platforms.[5]

Zymergen · zymergen.com · Same buyer (industrial and CPG partners), same workflow (strain engineering for novel molecules), and named together in talent flows and market maps.[5]

Codexis · codexis.com · Same buyer (industrial chemical and pharma partners seeking bio-catalysis), same budget line (bio-based ingredient R&D and manufacturing), and listed as competitor in enrichment data.[5]

Gevo · gevo.com · Same buyer (industrial chemical and fuel markets), same workflow (fermentation of sugars into hydrocarbon molecules), and listed as competitor in enrichment data.[5]

The customer proof is company-sourced only. No independent source in this ledger confirms it.[4]

Ask for one referenceable production customer.

Not a recommendation. The first thing this ledger cannot answer.

Filled in the side panel for invited readers. This card carries sourced facts only.